Mentice
Mentice builds VR and physical simulation platforms for image-guided interventional therapies, serving practicing interventional physicians, healthcare systems, and MedTech companies across neurovascular, cardiovascular, and peripheral vascular procedures. Its portfolio includes VIST simulators, Ankyras clinical decision support, and physiological flow systems.
- Company typePrivate
- Founded1999
- HeadquartersGothenburg, Sweden
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Mentice does
Mentice AB is a Swedish medical simulation company founded in 1999 and headquartered in Gothenburg, building virtual reality and physical simulation platforms for image-guided interventional therapies (IGIT). The company's core technology is the VIST (Vascular Intervention Simulation Trainer) hardware line (VIST G5 and G7), which uses haptic feedback, procedural replication, and integration with live angiosuites and interventional robotics to train and credential interventional neuroradiologists, cardiologists, and radiologists across neurovascular, cardiovascular, and peripheral vascular procedures. The portfolio also includes Physiological Flow Systems that reproduce realistic vascular disease states, the Vascular Twin (case-it) patient-specific anatomical replicator, the LAACS and Replicator PRO devices, and procedural learning modules covering more than 25 clinical areas. Following the 2022 acquisition of Ankyras from Galgo Medical S.L., Mentice operates a regulated clinical decision support application for intracranial flow diverter sizing, with manufacturing and R&D housed in Mentice Spain S.L. in Barcelona.
The company earns revenue through one-time hardware sales of simulator platforms and consumables (silicone and 3D-printed vessels, blood solutions, clot replication materials), recurring software revenue from AnkyRAS, Mentice Live, and learning modules, and professional services covering installation, training, and extended warranty. Pricing is quote-based under multi-year enterprise contracts, sold via direct field sales to healthcare systems and MedTech OEMs and supported by regional distributors in international markets. Named partners include Siemens Healthineers, Stryker, Cordis, and the Jacobs Institute. Mentice reports 115 employees, presence in 8 countries, and turnover of SEK 279 million in 2025, with strategic focus split between practicing physicians and trainees, healthcare executives standardizing training programs, and MedTech industry partners using Mentice solutions for device development, sales demonstration, and professional education.
Mentice firmographics
Firmographics- Name
- Mentice
- Legal name
- Mentice AB
- Website
- https://mentice.com
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Mentice builds VR and physical simulation platforms for image-guided interventional therapies, serving practicing interventional physicians, healthcare systems, and MedTech companies across neurovascular, cardiovascular, and peripheral vascular procedures. Its portfolio includes VIST simulators, Ankyras clinical decision support, and physiological flow systems.
- Ownership category
- akta.pro rank
Mentice industry classification
Industry- Product category
- Medical Simulation and Training
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Research and Development in the Physical, Engineering, and Life Sciences (54171)
- SIC
- Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction) (EDAFAJAC)
- akta.pro secondary industries
- Digital Twins & Scenario-Based Systems Training (Equipment/Process Simulators) (EDAFAJAJ), SaMD – Digital Biomarkers & Algorithmic Endpoints (HLACANAF)
Keywords
Where Mentice is headquartered
LocationHeadquarters
- HQ city
- Gothenburg
- HQ country
- Sweden
- HQ region
- Europe
Offices2 records
Markets served
Mentice business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure
Revenue model
- Virtual Simulation Platforms and Hardware: Sale of VR simulator platforms (VIST G5, VIST G7) and related hardware including flow systems, silicone vessels, and accessories. These are physical products sold as one-time purchases with associated consumables and service contracts.
- Software Licenses and Subscriptions: Software solutions including procedural learning modules, ANKYRAS clinical decision support application, and cloud-based Mentice Live platform. May include subscription-based access to software updates and cloud services.
- Professional Services: Installation, training, and extended warranty services, as well as device and procedural development services for MedTech industry partners
- Consumables: Flow system accessories including realistic blood solutions, clot replication materials, and cleaning solutions for physical simulators
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Enterprise healthcare systems pricing |
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
Mentice product offering
Product offeringCore offering
Mentice develops and sells virtual reality and physical simulation platforms for image-guided interventional therapies, including endovascular, neurovascular, cardiovascular, and peripheral vascular procedures. Its core product family is the VIST (Vascular Intervention Simulation Trainer) platform (G5 and G7), complemented by the Ankyras clinical decision support application for flow diverter sizing, Mentice Live cloud-based proctoring, Vascular Twin patient-specific anatomical replication, Physiological Flow Systems, and related consumables and learning modules used by hospitals, physicians, and MedTech companies.
Product overview
Mentice is a specialist in proficiency-based simulation solutions for image-guided interventional therapies (IGIT), offering both virtual reality and physical simulation platforms. The product portfolio centers on VIST (Vascular Intervention Simulation Trainer) hardware platforms (VIST G5 and G7), complemented by Ankyras (acquired 2022) for clinical decision support in flow diverter sizing, Vascular Twin for patient-specific anatomical replication, and cloud/mobile applications including Mentice Live and the Right Heart Cath App. The ecosystem includes Procedural Learning Modules (25+ clinical areas), Physiological Flow Systems for physical simulation, and supporting consumables. Solutions serve healthcare professionals (practicing physicians, residents, fellows) and MedTech industry (R&D, sales, professional education) across neurovascular, cardiovascular, and peripheral vascular specialties. Mentice operates from Gothenburg, Sweden with 115 employees and presence in 8 countries.
Differentiator
Problem solved
Functional benefit
Brands
- Ankyras: Clinical decision support application for flow diverter sizing in intracranial aneurysm treatment
- VIST (Vascular Intervention Simulation Trainer)
- Mentice Live
- Vascular Twin (case-it)
- Physiological Flow Systems
- Replicator PRO
- LAACS
Products and services
- VIST G7 Simulator Latest generation virtual reality vascular intervention simulation platform with advanced haptic feedback for realistic catheter and device manipulation training in neurovascular, cardiovascular, and peripheral vascular procedures; used by hospitals, training programs, and MedTech companies.
- VIST G5 Simulator Fifth generation haptic device-based endovascular simulator enabling realistic catheter and device manipulation training for interventional procedures; targeted at healthcare systems and training programs.
- Ankyras Clinical decision support software application that imports patient anatomy and determines the optimal flow diverter size for intracranial aneurysm treatment; used by interventional neuroradiologists and neurosurgeons, with CE MDR, UKCA, FDA 510(k), and ANVISA clearances.
- Mentice Live Cloud-based platform combining remote proctoring and online learning capabilities with medical simulation, enabling distributed training, curriculum delivery, and remote expert guidance for interventional teams.
- Vascular Twin (case-it) Real anatomical replication solution that imports patient CT, MRI, or 3DRA imaging to build a library of patient-specific cases for pre- and post-intervention practice.
- Right Heart Cath App Mobile application providing interactive, real-time exploration of the right heart catheterization (RHC) procedure for portable training access by interventional cardiologists and trainees.
- Physiological Flow Systems Physical simulation systems that replicate valvular, peripheral, aortic vascular, and neurovascular disease states with realistic blood flow for device and procedural training and adoption; used by hospitals and medical device manufacturers.
- Silicone & 3D Printed Vessels Patient-specific anatomical vessels in silicone and 3D printed formats, ordered to patient anatomy or chosen from a catalogue of anatomies for physical simulation training.
- Flow System Accessories Consumables for physical flow simulators, including realistic SIMulant blood solutions, clot replication and extraction materials, and cleaning solutions.
- Professional Services Professional services covering installation, training, and extended warranty for Mentice simulation platforms, plus device and procedural development services for MedTech industry partners.
Companies that use Mentice
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles3 records
Mentice technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability2 records
Feature6 records
Mentice partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered minor and core.
- VinnovaminorSwedish government innovation agency providing 3 million SEK grant to enhance realism in virtual reality software and synthetic image generation for medical AI training as part of the TASTI initiative within the European Eureka Xecs cluster.
- Galgo Medical S.L.coreAcquired all assets related to the Ankyras software solution for approximately EUR 2.775 million in cash. Ankyras provides flow diverter sizing for intracranial aneurysm treatment planning.
- Siemens HealthineerscoreCo-marketing partnership to advance neurovascular treatment planning. The partnership combines Mentice's simulation expertise with Siemens Healthineers' imaging technology to provide integrated solutions for neurovascular procedures.
- Jacobs InstitutecoreHealthcare innovation partner focused on advancing medical device development and training. Mentice provides simulation technology for the institute's education and research programs.
- StrykercoreStrategic MedTech partner using Mentice simulation solutions for device adoption, physician training, and demonstrating clinical credibility of their medical devices.
- CordiscoreMedTech industry partner leveraging Mentice solutions for procedural training and professional education related to Cordis medical devices.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
Mentice competitors and assessment
Company assessmentDirect peers
- Surgical Science Sweden AB: Swedish-headquartered medical simulation company offering virtual reality training platforms for interventional and surgical procedures. The closest direct competitor to Mentice, with overlapping endovascular, cardiovascular, and minimally invasive surgery simulation product lines and a shared Gothenburg regional base.
- VirtaMed: Swiss developer of high-fidelity virtual reality simulators for endovascular, laparoscopic, and ultrasound-guided procedures. Directly competes with Mentice in interventional cardiology, interventional radiology, and vascular access training served to the same MedTech and hospital buyers.
- Simbionix (3D Systems): 3D Systems' healthcare division produces the Simbionix line of VR-based procedural simulators for endovascular, bronchoscopy, GI, and general surgery. It is a direct competitor in virtual interventional simulation with comparable procedural content and an established global installed base.
- Medical-X: Netherlands-based developer of virtual reality and simulation-based training systems for minimally invasive surgery, endovascular, and interventional procedures. A direct competitor at the specialty-procedural simulator level with comparable product pricing tiers.
Broad incumbents
- CAE Healthcare: Healthcare division of CAE Inc. providing a broad portfolio of simulation-based training solutions spanning patient, ultrasound, interventional, and surgical modalities. While larger and broader than Mentice, it competes in healthcare simulation procurement at large hospital systems and MedTech training programs.
- Laerdal Medical: Norwegian-based global leader in medical simulation, including patient, emergency, and resuscitation training. While focused on patient simulators rather than interventional procedures, it competes at the healthcare-system training budget level and brings significant scale and distribution.
- Gaumard Scientific: U.S.-based manufacturer of patient simulators and simulation-based training solutions used across nursing, medical, and emergency response education. Operates broadly across healthcare simulation procurement where Mentice also targets healthcare executive buyers.
Emerging players
- Osso VR: VR-based surgical and procedural training platform for orthopedic, spine, and interventional procedures. Offers a software-first, more scalable model that competes with Mentice on content breadth and remote training capability (overlapping with Mentice Live).
- FundamentalVR: Haptic-enabled VR surgical training platform deployed via SaaS to MedTech and hospital customers. Competes with Mentice in MedTech professional education and surgical skills training, with a more software-centric approach.
- Inovus Medical: U.K.-based developer of synthetic and digital training solutions for surgical and interventional procedures, including laparoscopic and endovascular simulators. An emerging competitor addressing a portion of Mentice's procedural training market with cost-positioned offerings.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Mentice social profiles
Digital presenceMentice compliance and trust
Trust signalCompliance6 records
Mentice financial estimates
Financial estimateRevenue estimate
Valuation estimate
Mentice leadership team
Management profileNumber of profiles
Profiles5 records
Mentice subsidiaries and ownership
Company hierarchySubsidiaries2 records
Mentice funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Mentice M&A and investment
M&A and investmentM&A4 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Mentice
What does Mentice do?
Mentice develops and sells virtual reality and physical simulation platforms for image-guided interventional therapies, including endovascular, neurovascular, cardiovascular, and peripheral vascular procedures. Its core product family is the VIST (Vascular Intervention Simulation Trainer) platform (G5 and G7), complemented by the Ankyras clinical decision support application for flow diverter sizing, Mentice Live cloud-based proctoring, Vascular Twin patient-specific anatomical replication, Physiological Flow Systems, and related consumables and learning modules used by hospitals, physicians, and MedTech companies.
Is Mentice a public or private company?
Mentice is a private company. It is classified as public and is currently operating.
When was Mentice founded?
Mentice was founded in 1999. It employs 101 to 250 people.
Where is Mentice based?
Mentice is headquartered in Gothenburg, Sweden, in the Europe region.
How does Mentice make money?
Four revenue lines are on record. Virtual Simulation Platforms and Hardware is the primary driver. The others are software Licenses and Subscriptions, professional Services and consumables.
Who are Mentice's main competitors?
Direct peers on record are Surgical Science Sweden AB, VirtaMed, Simbionix (3D Systems) and Medical-X. Broad incumbents are CAE Healthcare, Laerdal Medical and Gaumard Scientific. Emerging players are Osso VR, FundamentalVR and Inovus Medical.
Does Mentice have an API?
No public API is recorded for Mentice.
What industry is Mentice in?
Mentice's product category is Medical Simulation and Training. Its primary akta.pro industry code is EDAFAJAC, Healthcare & Clinical Simulation (Surgery, Nursing, EMT, Patient Interaction), with a secondary code of EDAFAJAJ, Digital Twins & Scenario-Based Systems Training (Equipment/Process Simulators). Its NAICS code is 334510 and its SIC code is 3841.